key: cord-0331853-6csqn2id
authors: Lutrick, K.; Groom, H.; Fowlkes, A.; Groover, K.; Gaglani, M.; Rivers, P.; Naleway, A.; Nguyen, K.; Herring, M.; Dunnigan, K.; Phillips, A.; Parker, J.; Prather, K.; Thiese, M. S.; Baccam, Z.; Tyner, H.; Yoon, S.
title: COVID-19 Vaccine Perceptions and Uptake in a National Prospective Cohort of Essential Workers
date: 2021-10-23
journal: nan
DOI: 10.1101/2021.10.20.21265288
sha: e21bdce873b73757941eae8aa2cc52eb8bf68e48
doc_id: 331853
cord_uid: 6csqn2id

Introduction: In a multi-center prospective cohort of essential workers, we assessed knowledge, attitudes, and practices (KAP) by vaccine intention, prior SARS-CoV-2 positivity, and occupation, and their impact on vaccine uptake over time. Methods: Initiated in July 2020, HEROES-RECOVER cohort provided socio-demographics and COVID-19 vaccination data. Using follow-up two surveys approximately three months apart, COVID-19 vaccine KAP, intention, and receipt was collected; the first survey categorized participants as reluctant, reachable, or endorsers. Results: A total of 4,803 participants were included in the analysis. Most (70%) were vaccine endorsers, 16% were reachable, and 14% were reluctant. By May 2021, 77% had received at least one vaccine dose. KAP responses strongly predicted vaccine uptake, particularly positive attitudes about safety (aOR=5.46, 95% CI: 1.4-20.8) and effectiveness (aOR=5.0, 95% CI: 1.3-19.1). Participants prior SARS-CoV-2 infection were 22% less likely to believe the COVID-19 vaccine was effective compared with uninfected participants (aOR 0.78, 95% CI: 0.64-0.96). This was even more pronounced in first responders compared with other occupations, with first responders 42% less likely to believe in COVID-19 vaccine effectiveness (aOR=0.58, 95% CI 0.40-0.84). KAP responses shifted positively, with reluctant and reachable participant scores modestly increasing in positive responses for perceived vaccine effectiveness (7% and 12%, respectively) on the second follow-up survey; 25% of initially reluctant participants received the COVID-19 vaccine. Discussion: Our study demonstrates attitudes associated with COVID-19 vaccine uptake and a positive shift in attitudes over time. First responders, despite potential high exposure to SARS-CoV-2, and participants with a history of SARS-CoV-2 infection were more vaccine reluctant. Conclusions: COVID-19 vaccine KAP responses predicted vaccine uptake and associated attitudes improved over time. Perceptions of the COVID-19 vaccine can shift over time. Targeting messages about vaccines safety and effectiveness in reducing SARS-CoV-2 virus infection and illness severity may increase vaccine uptake for reluctant and reachable participants.

The SARS-CoV-2 pandemic has resulted in high levels of morbidity and mortality in the 100 US. 1 In response, a global effort to develop COVID-19 vaccines generated evidence leading to 101 the U.S. Food and Drug Administration (FDA) authorizing COVID-19 vaccines under an 102

Emergency Use Authorization (EUA) mechanism, beginning in mid-December 2020. 2 Essential 103 workers, including healthcare personnel (HCP), first responders, and other frontline workers 104 (FW), may be at an increased risk of SARS-CoV-2 infection because of their high rates of 105 contact with patients, coworkers, or the general public 3-7 and were prioritized to receive COVID-106

Immunization Practices during initial, staggered distribution. 108

The COVID-19 vaccines have been shown to be safe and effective in adults and children 109 ages 12 and older, but the initial high demand for vaccination has decreased. 8 Prior to COVID-19 110 vaccine authorization and availability in December 2020, early studies in the United States (US) 111 reported rates of willingness to receive the COVID-19 vaccine ranging widely from 40% to 112 75%. 9-18 Additionally, first responders and FW have reported lower rates of vaccine acceptance 113 than HCP. 12,14 Common reasons for vaccine hesitancy included the novelty of the COVID-19 114 vaccines, concerns about potential adverse effects, and/or a distrust in government. 9-14 115 There is some indication that COVID-19 vaccine acceptance has changed over time in 116 cross-sectional surveys. 12, 19 It is unclear how individual vaccination intention has evolved as the 117 public, has gained more information regarding symptoms and outcomes of COVID-19 disease 118 and risks and benefits of vaccinations. 119

Knowledge, attitudes, and practices (KAP) toward vaccination are often examined to 120 understand factors associated with the acceptability of vaccines and inform strategies for 121 1 subsequent three months (supplemental Figure 1 for study timing). Beginning in December 2020, 145 participants were prompted to report uptake of COVID-19 vaccine; vaccine survey distribution 146 was based on vaccine availability data from state and county health departments. Vaccination 147 was verified by participant-provided vaccine cards, electronic medical records, or State 148 Immunization Information Systems. All protocols were reviewed and approved by each site's 149 Institutional Review Boards; study participants provided informed consent for all study 150 activities. Vaccine intention was derived using participants' first response to the question, "What 157 are the chances that you will get a COVID-19 vaccination?" and vaccination status at the time of 158

Follow-up survey 1. Participants were grouped into three intention categories: 1) reluctant as 159 those who answered, "almost zero chance", or "very small chance", and were unvaccinated, 2) 160 reachable as those who answered "small chance", "do not know", or "moderate" and were 161 unvaccinated, or 3) endorser as those who answered, "large chance", "very large chance", or 162 "almost certain", or were vaccinated at Follow-up survey 1. New vaccine receipt after Follow-up 163 survey 1 was monitored and the participants' vaccine intention group did not change based upon 164

Follow-up survey 2 KAP responses. 165

Participants were asked six questions to assess the KAP constructs regarding COVID-19: 166 knowledge of SARS-CoV-2 and COVID-19 vaccines; attitudes about safety, effectiveness, trust 167 1 in the government, and perceived risk of becoming ill if they were not vaccinated (Table 1Table  168 1). Responses to each question were rated on a 5-to 7-level Likert scale indicating lowest to 169 highest ranking. 170

For models examining KAP differences and predictors of vaccination, socio-172 demographics, including gender, age, race, ethnicity, education, household income, occupation 173 and occupational setting, and participant health status, including SARS-CoV-2 infection status, 174 COVID-19 vaccination status, and medical history were included. HCP occupation categories 175 are categorized as any individual that works in a hospital as "HCP inpatient", any individual that 176 works in any outpatient healthcare facility or long-term care facility as "HCP other". We created 177 two first responder categories: 1) firefighter (firefighters/EMS) and 2) other first responders (law 178 enforcement, correctional officers, and border patrol). FW public-facing included individuals 179 that work in education settings, retail, food service, and hospitality. Other FW include 180 individuals that work in infrastructure, manufacturing, warehouse, utility, and transportation. 181

In models examining Objectives 1 and 2, COVID-19 contact data were reported as the 182 number of hours spent at work (1) in any setting and in direct contact with individuals with 183 suspected or confirmed COVID-19 and (2) the general public in the past 7 days. They also 184 indicated the percent of time protective equipment (PPE) was used during this contact. belief that the vaccine is effective (aOR=4.98 95% CI: 1.30-19.14) ( Table 3) . 247

Vaccine Intention Groups. Only 17% of reluctant (n=109) and 33% of reachable 249 participants (n=252) reported concern about getting sick if unvaccinated compared with 48% of 250 endorsers (n=1624) ( Table 2) . Similarly, reluctant and reachable participants were more likely to 251 report negative attitudes about vaccine safety (82% and 56%, respectively), vaccine effectiveness 252 (76% and 51%, respectively), and trust in the government (79% and 58%, respectively 

To evaluate change in KAP over time, 2017 (49%) participants that completed both 285

Follow-up 1 and 2 surveys were included. Among initially 383 reluctant participants, 94 (25%) 286 received COVID-19 vaccine; 195 (56%) reachable and 1,232 (83%) endorsers were also 287 vaccinated. Demographic characteristics among reluctant and reachable participants who were 288 vaccinated after initial categorization did not differ from unvaccinated participants. Among 289 endorsers, unvaccinated participants were more likely to be male (p=0.017), younger (p=0.014)), 290 and firefighters (p<0.001) than endorsers that were vaccinated ( 291 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 23, 2021. ; Table ) . 292

When evaluating KAP over time, reluctant participants that did not get vaccinated had a 293 9% decrease in positive responses to questions about their knowledge of the virus between 294

Follow-up survey 1 and 2 (Error! Reference source not found.). The change in positive 295 response to vaccine knowledge increased by 20% and 21% for the non-vaccinated and 296 vaccinated, respectively. However, there was a 7% increase in positive response toward vaccine 297 effectiveness in those that were not vaccinated compared to a 31% increase for vaccinated 298 participants. The HEROES-RECOVER prospective cohort provided a unique opportunity to examine 309 COVID-19 vaccine knowledge, attitudes, and practices longitudinally in a large population of 310 essential workers with high occupational COVID-19 exposure. The prospective design allowed 311 for assessment of vaccination intent as well as vaccine uptake. 312

We found KAP responses were strongly associated with vaccine uptake. Our cohort 313 largely reported more positive attitudes toward the COVID-19 vaccine than other national 314 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 23, 2021. ; cohorts, 12-15 with more than two-thirds of participants expressing strong intent to be vaccinated. 315

We also found strong associations between KAP responses and vaccine intention groups, with 316 vaccine reluctant participants more likely to have negative attitudes towards safety and 317 effectiveness and less likely to be vaccinated. While we found that a substantial proportion of our 318 high-risk cohort population reported an initial reluctance to receive COVID-19 vaccine, 319 ultimately one quarter of those reluctant were vaccinated by May 19, 2021. and suggest that these negative attitudes persisted even after more data became available on the 335 safety and efficacy of available vaccines. 336 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 23, 2021. ;

KAPs and Vaccine Uptake. Across intent to vaccinate, demographics, occupation, and 337 prior SARS-CoV-2 infection groups, three KAP domains were consistently correlated with intent 338 to vaccinate and vaccine uptake: safety, effectiveness, and the chance of getting sick if not 339 vaccinated. We found knowledge about the SARS-CoV-2 virus, or the COVID-19 vaccine had 340 no association with vaccine uptake. It is difficult to ascertain whether participants who perceive 341 themselves to be knowledgeable are truly informed, but attitudes about vaccine safety and 342 effectiveness appear to be more informative of individual intentions to vaccinate. Vaccination 343 efforts that highlight vaccine safety and effectiveness may have a stronger influence on 344 vaccination uptake than general or historical information. We found positive attitudes align with 345 vaccine uptake and imply that KAP assessments to gauge a population's intentions or concerns 346 in advance of vaccination campaigns is critical. 347

Unsurprisingly, the majority of HCP were endorsers of the vaccine, and the vast majority 348 received the COVID-19 vaccine. Some HCP occupational groups have low vaccination coverage 349 nationally, 17,18 and so our study population may not be representative of those groups. Other 350 frontline workers, which for this study included teachers, retail workers, and manufacturing were 351 not as positive towards the vaccine as HCP, though the vast majority were still considered 352 endorsers and reachable and were vaccinated at higher rates than first responders. The COVID-353 19 pandemic has clearly demonstrated the critical nature of the essential worker role and need for 354 additional investigations. 355 KAP Change Over Time. Utilizing the prospective cohort, we were able to examine 356 shifts in KAP over time, subgrouping vaccinated versus unvaccinated participants. The KAP 357 factors that were most connected to vaccination remained influential over time. We identified 358 more positive shifts in responses between the two time points in those participants ultimately 359 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 23, 2021. ; https://doi.org/10.1101/2021.10.20.21265288 doi: medRxiv preprint vaccinated, specifically in response to perceived safety and effectiveness across all intention 360 groups. Interestingly, even those participants that were not vaccinated demonstrated a positive 361 increase in perceived vaccine safety and effectiveness over the three-month period. 362

Our findings are consistent with other studies conducted prior to COVID-19 vaccine 363 authorization and availability. 14,16 While vaccine intent was assessed in our study after the FDA 364 granted EUA, our findings capture an initial uncertainty that was seemingly overcome with time 365 and positive findings for vaccine safety and effectiveness. 12 366

Limitations. This study is subject to several limitations. First, the follow-up surveys 367

were spread out over about six weeks due to site's individual IRB timelines. As the level of 368 information available evolved quickly during the study period, participants at sites where the 369 follow-up surveys were administered later may have had access to a meaningfully different 370 amount, or quality, of information. Secondly, all KAPs are self-reported and there may be a 371 disconnect between perceived knowledge and actual level of knowledge. Next, while we are 372 confident KAPs are successfully captured in our cohorts at the time of administration, due to the 373 novelty of the COVID-19 vaccine, KAPs will likely continue to change and evolve past this 374 analysis period. Finally, the mechanism prompting change in KAPs is not captured, so it is 375 difficult to know why certain KAPs changed as they did over time, e.g., the change in certain 376

KAPs between the two follow-up surveys may have been due to increased numbers of 377 participants receiving the vaccine with few documented serious adverse event rates, increased 378 access to information and disease/vaccine literacy, changes in national and local COVID-19 379 incidence. The demographic characteristics of the group that answered Follow-up 2 different 380 slightly from those that completed Follow-up 1: there were more female participants (64% vs 381 60%), they were older (45% 40-65 years of age compared to 36%), and there were higher 382 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 23, 2021. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 23, 2021. ; All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 23, 2021. ; 1937 (57.3%) Reluctant participants indicated low likelihood of being vaccinated, Reachable participants mentioned a moderate likelihood of being unvaccinated, and Endorser participants indicated a high likelihood of being vaccinated or were already vaccinated; a People who answered the KAP questions after being vaccinated were considered endorsers to get vaccinated; b Only asked to unvaccinated participants in non-AZ sites; Likert responses were condensed from 5 to 8 categories (depending on the question) to negative/neutral and positive * Proportions may differ due to missing data not shown or small numbers sequestered 566 567 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 23, 2021. ; (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Statistical significance based on 95% confidence intervals. b Non-significant adjusted point estimates and confidence intervals not reported. Bonferroni corrections were used for each of vaccination status, intention group, occupation, and prior positivity. The model was adjusted for socio-demographics, occupation and occupational setting, vaccine intention, and prior positivity for SARS-CoV-2 infection.

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 23, 2021. ; (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 23, 2021. ;

for Disease Control and Prevention

US Food & Drug Administration. Pfizer-BioNTech COVID-19 Vaccine

Estimating Coronavirus Disease 2019 Infection Risk in 486 Health Care Workers

Risk of COVID-19 among front-line health-488 care workers and the general community: a prospective cohort study. The Lancet Public 489 Health

A disproportionate epidemic: COVID-19 cases and 491 deaths among essential workers in Toronto, Canada. medRxiv. 2021. 492 6. Centers for Disease Control and Prevention. Interim List of Categories of Essential 493 Workers Mapped to Standardized Industry Codes and Titles

The Advisory Committee on 497 Immunization Practices' Interim Recommendation for Allocating Initial Supplies of 498 COVID-19 Vaccine -United States

Centers for Disease Control and Prevention. COVID data tracker: COVID-19 501 vaccinations in the United States